Another important finding in the present work is that the TKT1 gene is not overexpressed in CNS WHO grade 1 and 2 gliomas, while in CNS WHO grade 3 and 4 gliomas, it shows an increase in expression, which correlates well with the CNS WHO disease grade (Figure 3). This evidence concerns the gene TKT and glioma.